Skip to content

Phagenesis

Phagenesis is a medical device company behind the Phagenyx System, which uses pharyngeal electrical stimulation to treat neurogenic dysphagia.

Last updated September 16, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Phagenesis is a company focused on transforming the treatment of neurogenic dysphagia. Its Phagenyx System applies pharyngeal electrical stimulation (PES) to sensory nerves to restore the brain's control of swallowing function, aiming to improve swallowing safety and efficiency and accelerate recovery from post-stroke dysphagia. The company describes itself as built on pioneering research into the brain-to-swallow connection and states that the Phagenyx System is supported by 30+ publications and enables rapid, early bedside intervention without disrupting clinical workflow.

History

Phagenesis states it was built on pioneering research into the brain-to-swallow connection. The company reports being the first to map the swallow motor cortex in both healthy individuals and patients with disease, and the first to demonstrate that recovery from dysphagia is associated with functional reorganization of the swallow motor cortex. Its Phagenyx System applies pharyngeal electrical stimulation (PES) to sensory nerves to restore the brain's control of swallowing function.

Products and positioning

Leader in delivering targeted pharyngeal electrical stimulation to restore neural pathways for safe, efficient swallowing.

  • Phagenyx System

    A system that applies pharyngeal electrical stimulation (PES) to sensory nerves to restore the brain's control of swallowing function, improving swallowing safety and efficiency and accelerating recovery from post-stroke dysphagia.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/phagenesis-united-kingdom · Editorial policy · How profiles are compiled